The Hydration Pharmaceuticals Company Ltd Cash Flow-to-Debt Ratio
The Hydration Pharmaceuticals Company Ltd cash flow-to-debt ratio. The Hydration Pharmaceuticals Company Ltd (HPC) has a Cash Flow-to-Debt Ratio of -1.34x as of June 2025, meaning its operating cash flow of AU$-1.64 Million could theoretically repay -1% of its total liabilities (AU$1.22 Million) in one year. Check HPC cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of The Hydration Pharmaceuticals Company Ltd (2018–2024)
Cash flow-to-debt ratio of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024. Historical debt coverage capacity for The Hydration Pharmaceuticals Company Ltd across 7 annual periods. Also explore how fast is The Hydration Pharmaceuticals Company Lt growing its equity to track the company's year-over-year net asset growth rate.
The Hydration Pharmaceuticals Company Ltd Cash Flow-to-Debt Ratio by Year (2018–2024)
The Hydration Pharmaceuticals Company Ltd cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for The Hydration Pharmaceuticals Company Ltd. For the full cash flow conversion analysis, see The Hydration Pharmaceuticals Company Lt cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.34x | AU$-3.02 Million | AU$2.25 Million | ▼ -64.8% |
| 2023 | -0.81x | AU$-5.73 Million | AU$7.05 Million | ▲ +46.6% |
| 2022 | -1.52x | AU$-9.75 Million | AU$6.41 Million | ▲ +60.8% |
| 2021 | -3.89x | AU$-8.08 Million | AU$2.08 Million | ▼ -145.8% |
| 2020 | -1.58x | AU$-3.86 Million | AU$2.44 Million | ▲ +0.2% |
| 2019 | -1.58x | AU$-2.78 Million | AU$1.76 Million | ▲ +53.7% |
| 2018 | -3.42x | AU$-5.40 Million | AU$1.58 Million | — |